Method of controlling androstene levels in vivo with cobalt porphyrins
US5063223A · kind A · utility
2Cited by
3References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 23, 1990 |
| Grant date | Nov 5, 1991 |
| Priority date | — |
| Expiry date | Mar 23, 2010 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/409
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Method of reducing the production of gonadal estrogenic steroidal hormones in animals by parenteral administration of defined quantities of cobalt protoporphyrin or cobalt mesoporphyrin.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.